QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2026 RESULTS

Quaker Houghton’s Q3 2026 net sales rose 10% year over year to $544.5 million, while adjusted EBITDA increased 8% to $89.8 million and non-GAAP diluted EPS climbed 15% to $2.39. GAAP net income was $30.0 million, down from $30.5 million a year earlier; nine-month operating cash flow fell to $47.6 million from $89.9 million. Management expects Q4 revenue and adjusted EBITDA to improve year over year but decline sequentially from Q3’s record level, citing seasonal demand, soft China activity, and elevated raw-material costs amid Middle East conflict.

Analysis

The quality of growth is mixed: underlying customer activity was flat to slightly weaker, so volume gains point to share capture rather than a broad industrial rebound. That is constructive for KWR’s competitive position, but not yet evidence of end-market operating leverage. Price/mix is doing much of the work while non-GAAP gross margin and adjusted EBITDA margin both contracted year over year—consistent with input-cost recovery lagging or mix pressure. If raw materials stay elevated, pricing cadence and contract indexation, rather than headline sales growth, will determine whether earnings momentum holds.

The more important near-term risk is cash conversion. Working-capital absorption has materially weakened operating cash flow, while net leverage leaves less room for prolonged inventory/receivables buildup or another demand shock. The Americas appears the strongest engine; EMEA’s sales growth is price-led against lower volume, while Asia/Pacific’s margin pressure makes China softness a direct earnings risk. Competitors with better pricing discipline could gain share if KWR’s pass-through begins to impair customer economics.

Immediate reaction may favor the adjusted EPS and record EBITDA narrative, but the Oct. 30 call is the key 1–3 month catalyst: listen for lagged cost recovery, working-capital normalization, and evidence that new wins are converting to profitable volume. Over 6–18 months, durable share gains could support earnings even in a weak cycle; repeated restructuring/transformation addbacks and weak cash conversion would undermine the quality of that growth. The contrarian angle is that this is not yet a clean cyclical recovery—headline growth risks overstatement, but share gains could be undervalued if margins and cash conversion turn.

Key Decisions for Investors

• Do not chase the initial earnings headline; keep KWR on a conditional long watchlist pending the Oct. 30 call. Require evidence of improving gross/adjusted EBITDA margins and a credible path to working-capital release before adding exposure.
• For existing longs, retain a measured position but avoid adding ahead of confirmation: the combination of roughly 2.3x net leverage and weaker cash generation raises downside sensitivity if China or broader industrial demand deteriorates.
• Track receivables, inventory, operating cash flow, and price-versus-raw-material cost recovery next quarter. Thesis weakens if working capital continues to consume cash or margins contract despite price actions; it strengthens if cash conversion improves while volume wins persist.
• No options trade is warranted without share price, implied volatility, and valuation context. Reassess after the call rather than expressing a directional view solely on adjusted EPS growth.